Cristina Chamizo

1.1k total citations
26 papers, 692 citations indexed

About

Cristina Chamizo is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Cristina Chamizo has authored 26 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Cristina Chamizo's work include HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cancer-related Molecular Pathways (4 papers). Cristina Chamizo is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cancer-related Molecular Pathways (4 papers). Cristina Chamizo collaborates with scholars based in Spain, United Kingdom and United States. Cristina Chamizo's co-authors include Javier Moreno, Jorge Alvar, Federico Rojo, Sandra Zazo, Juan Madoz‐Gúrpide, Ana Rovira, Joan Albanell, Aňa Lluch, Pîlar Eroles and Ion Cristóbal and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Cristina Chamizo

26 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cristina Chamizo Spain 13 266 263 210 161 110 26 692
Tuhina Mazumdar United States 17 398 1.5× 232 0.9× 148 0.7× 146 0.9× 143 1.3× 32 785
María C. Ramello Argentina 15 183 0.7× 494 1.9× 94 0.4× 156 1.0× 511 4.6× 23 918
Chen‐Feng Qi United States 13 532 2.0× 173 0.7× 160 0.8× 79 0.5× 734 6.7× 15 1.4k
H G Drexler Germany 17 318 1.2× 153 0.6× 87 0.4× 60 0.4× 216 2.0× 26 810
H. Mann Germany 9 225 0.8× 189 0.7× 79 0.4× 64 0.4× 312 2.8× 21 813
Charles H. Pletcher United States 12 196 0.7× 244 0.9× 25 0.1× 42 0.3× 364 3.3× 18 722
Sourindra Maiti United States 14 655 2.5× 456 1.7× 101 0.5× 94 0.6× 233 2.1× 16 1.2k
Seri Mustafah Singapore 6 280 1.1× 105 0.4× 82 0.4× 56 0.3× 348 3.2× 6 676
Jennifer M. Reiman United States 11 377 1.4× 498 1.9× 135 0.6× 37 0.2× 363 3.3× 13 939
Maria Belen Delgado Switzerland 12 187 0.7× 389 1.5× 75 0.4× 61 0.4× 523 4.8× 13 868

Countries citing papers authored by Cristina Chamizo

Since Specialization
Citations

This map shows the geographic impact of Cristina Chamizo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Chamizo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Chamizo more than expected).

Fields of papers citing papers by Cristina Chamizo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina Chamizo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Chamizo. The network helps show where Cristina Chamizo may publish in the future.

Co-authorship network of co-authors of Cristina Chamizo

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina Chamizo. A scholar is included among the top collaborators of Cristina Chamizo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina Chamizo. Cristina Chamizo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prieto‐Potín, Iván, Ana Suárez‐Gauthier, Cristina Chamizo, et al.. (2022). Comprehensive Approach to Genomic and Immune Profiling: Insights of a Real-World Experience in Gynecological Tumors. Diagnostics. 12(8). 1903–1903. 3 indexed citations
2.
Manso, Rebeca, Cristina Chamizo, Pablo Mínguez, et al.. (2021). INTESTINAL T‐CELL LYMPHOMAS: MOLECULAR INTEGRATIVE ANALYSIS RECOGNIZES DIFFERENT THERAPEUTIC TARGETS FOR EACH SUBTYPE. Hematological Oncology. 39(S2). 1 indexed citations
3.
Zazo, Sandra, Paula Gónzález-Alonso, Ester Martı́n-Aparicio, et al.. (2020). Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer. Molecular Cancer Therapeutics. 19(8). 1696–1707. 24 indexed citations
4.
Prieto‐Potín, Iván, Rebeca Manso, Cristina Chamizo, et al.. (2020). Validation and clinical application of a targeted next-generation sequencing gene panel for solid and hematologic malignancies. PeerJ. 8. e10069–e10069. 1 indexed citations
5.
Manso, Rebeca, Olga Balagué, Cristina Chamizo, et al.. (2020). Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution?. PLoS ONE. 15(11). e0241634–e0241634. 7 indexed citations
6.
Gónzález-Alonso, Paula, Sandra Zazo, Ester Martı́n-Aparicio, et al.. (2020). The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer. Cancers. 12(5). 1108–1108. 21 indexed citations
7.
Gónzález-Alonso, Paula, Ion Cristóbal, Sandra Zazo, et al.. (2018). Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models. Current Medicinal Chemistry. 25(17). 1976–1998. 3 indexed citations
8.
Rincón, Raúl, Sandra Zazo, Cristina Chamizo, et al.. (2016). c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer. Molecular Cancer Therapeutics. 15(11). 2780–2790. 12 indexed citations
9.
Zazo, Sandra, Paula Gónzález-Alonso, Ester Martı́n-Aparicio, et al.. (2016). Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines.. PubMed. 6(11). 2661–2678. 37 indexed citations
10.
Chamizo, Cristina, Sandra Zazo, Manuel Dómine, et al.. (2015). Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer. BMC Pulmonary Medicine. 15(1). 132–132. 16 indexed citations
11.
Chamizo, Cristina, Federico Rojo, & Juan Madoz‐Gúrpide. (2015). Determination of True ERBB2 Gene Amplification in Breast Cancer by Quantitative PCR Using a Reference and a Novel Control Gene. Applied immunohistochemistry & molecular morphology. 24(3). 179–187. 6 indexed citations
12.
Madoz‐Gúrpide, Juan, Sandra Zazo, Cristina Chamizo, et al.. (2015). Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer. Journal of Translational Medicine. 13(1). 282–282. 66 indexed citations
13.
García-Parra, Jetzabel, Alba Dalmases, Beatriz Morancho, et al.. (2014). Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer. European Journal of Cancer. 50(15). 2725–2734. 22 indexed citations
14.
Puerto‐Nevado, Laura del, Federico Rojo, Sandra Zazo, et al.. (2014). Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy. British Journal of Cancer. 110(11). 2700–2707. 21 indexed citations
15.
Rojo, Federico, Laia Domingo, María Sala, et al.. (2013). Gene Expression Profiling in True Interval Breast Cancer Reveals Overactivation of the mTOR Signaling Pathway. Cancer Epidemiology Biomarkers & Prevention. 23(2). 288–299. 10 indexed citations
16.
Rojo, Federico, Jetzabel García-Parra, Sandra Zazo, et al.. (2011). Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Annals of Oncology. 23(5). 1156–1164. 151 indexed citations
17.
Chamizo, Cristina, Javier Moreno, & Jorge Alvar. (2004). Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Veterinary Immunology and Immunopathology. 103(1-2). 67–75. 92 indexed citations
18.
Chamizo, Cristina, José Miguel Rubio, Javier Moreno, & Jorge Alvar. (2001). Semi-quantitative analysis of multiple cytokines in canine peripheral blood mononuclear cells by a single tube RT-PCR. Veterinary Immunology and Immunopathology. 83(3-4). 191–202. 31 indexed citations
19.
Moreno, Javier, Carmen Cañavate, Cristina Chamizo, F Laguna, & Jorge Alvar. (2000). HIV-Leishmania infantum co-infection: humoral and cellular immune responses to the parasite after chemotherapy. Transactions of the Royal Society of Tropical Medicine and Hygiene. 94(3). 328–332. 29 indexed citations
20.
Moreno, Javier, Javier Nieto, Cristina Chamizo, et al.. (1999). The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy. Veterinary Immunology and Immunopathology. 71(3-4). 181–195. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tuhina Mazumdar Breakdown of academic impact, for papers by María C. Ramello Breakdown of academic impact, for papers by Chen‐Feng Qi Breakdown of academic impact, for papers by H G Drexler Breakdown of academic impact, for papers by H. Mann Breakdown of academic impact, for papers by Charles H. Pletcher Breakdown of academic impact, for papers by Sourindra Maiti Breakdown of academic impact, for papers by Seri Mustafah Breakdown of academic impact, for papers by Jennifer M. Reiman Breakdown of academic impact, for papers by Maria Belen Delgado
Rankless by CCL
2026